The aim of this study is to scale-up implementation of bidirectional screening of COVID-19 and TB at health facility…
STUDY DETAILS
- Category Current Studies
XACT – III A randomized controlled trial (RCT) to evaluate a scalable active case-finding intervention for TB using a point-of-care molecular tool (Gene Xpert)
To evaluate the multi-country efficacy and feasibility of tuberculosis active case-finding using a portable battery-powered molecular diagnostic platform (Xpert) installed within a low-cost scalable mobile mini-clinic using a Nissan panel van staffed by 3 health care workers.
Participant recruitment is ongoing.
Start: November 2021 – runs for 48 months
Funded by EDCTP/DFID
RELATED STUDIES
The aim is to systematically evaluate the burden and describe the natural history of cardiac disease…
Intervention co-development to increase men’s HIV service use. The study aims to co-design, with men, healthcare…
This PhD programme is run by a DFID consortium on disability research run by LSHTM. Zambart with UNZA…